NOMURA HOLDINGS INC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
NOMURA HOLDINGS INC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$29,409,000
-52.7%
405,511
-46.0%
0.11%
-21.4%
Q2 2019$62,142,000
+217.9%
750,898
+168.2%
0.14%
+68.7%
Q1 2019$19,547,000
+516.4%
279,987
+296.9%
0.08%
+591.7%
Q4 2018$3,171,000
-79.6%
70,546
-74.5%
0.01%
-78.2%
Q3 2018$15,550,000
-24.9%
277,009
-10.7%
0.06%
-16.7%
Q2 2018$20,716,000
-59.5%
310,115
-63.4%
0.07%
+120.0%
Q1 2018$51,156,000
+179.3%
848,223
+198.4%
0.03%
-9.1%
Q4 2017$18,316,000
+45.1%
284,261
+18.2%
0.03%
+22.2%
Q3 2017$12,620,000
+29.5%
240,528
+14.9%
0.03%
+12.5%
Q2 2017$9,744,000
-5.9%
209,349
+0.2%
0.02%
-11.1%
Q1 2017$10,352,000
-17.7%
208,901
+0.6%
0.03%
-15.6%
Q4 2016$12,571,000
-8.3%
207,737
+0.7%
0.03%
-15.8%
Q3 2016$13,703,000
+35.8%
206,391
+14.0%
0.04%
+15.2%
Q2 2016$10,094,000
+13919.4%
181,064
+8448.8%
0.03%
Q1 2016$72,000
-99.0%
2,118
-98.7%
0.00%
-100.0%
Q4 2015$7,519,000
+16.0%
166,750
+2.6%
0.02%
-8.7%
Q3 2015$6,481,000
-28.0%
162,513
+7.3%
0.02%
-8.0%
Q2 2015$9,007,000
-0.2%
151,497
+1.7%
0.02%
-16.7%
Q1 2015$9,029,000
+1492.4%
149,001
+1331.1%
0.03%
+1400.0%
Q4 2014$567,00010,4120.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders